In terms of clinical implications, our findings regarding CD147’s role in mediating 5-FU resistance have potential relevance for breast cancer patients because understanding the molecular mechanisms behind resistance can inform treatment strategies and the development of combination therapies that target CD147 alongside 5-FU may enhance treatment efficacy and overcome resistance. Here, BSG is linked to breast carcinoma.